Old Web
English
Sign In
Acemap
>
authorDetail
>
T Mertenskoetter
T Mertenskoetter
Business
Microbicide
cost effectiveness
human immunodeficiency virus
Medicine
5
Papers
9
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Model projections of the population-level impact, on HIV and herpes simplex virus type-2 (HSV-2), and cost-effectiveness of tenofovir gel, an antiretroviral microbicide
2012
A Foss
Fern Terris-Prestholt
Ap Cox
Lori Heise
Gesine Meyer-Rath
Sinead Delany-Moretlwe
T Mertenskoetter
Helen Rees
Peter Vickerman
Charlotte Watts
Show All
Source
Cite
Save
Citations (1)
Ensuring that Developing Countries have Access to New Healthcare Products: The Role of Product Development Partnerships
2010
A. D. Brooks
W.A Wells
T.D. McLean
R. Khanna
R. Coghlan
T Mertenskoetter
L.A. Privor-Dumm
A. Krattiger
R. T. Mahoney
Show All
Source
Cite
Save
Citations (5)
Making realistic impact projections for new HIV prevention technologies: looking beyond a product’s efficacy
2009
Ap Cox
A Foss
Peter Vickerman
C. Chimbwete
E Okonji
Fern Terris-Prestholt
M Beksinska
Sibongile Walaza
C. von Mollendorf
Jenni Smit
C. Mias
T Mertenskoetter
Jocelyn Moyes
Sinead Delany-Moretlwe
Helen Rees
Lilani Kumaranayake
Charlotte Watts
Show All
Source
Cite
Save
Citations (0)
Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT)
2009
European Journal of Medical Research
K Arasteh
Lutwin Weitner
Stefan Fenske
B Kühlmann
M. Freiwald
R. Ebrahimi
L. Gallo
B Ranneberg
T Mertenskoetter
Show All
Source
Cite
Save
Citations (3)
Strategies for microbicide distribution in India and South Africa: Modeling and cost-effectiveness analyses
2009
Charlotte Watts
Ap Cox
A Foss
Peter Vickerman
Lilani Kumaranayake
Fern Terris-Prestholt
C. Mias
P. Kaptur
T Mertenskoetter
Show All
Source
Cite
Save
Citations (0)
1